Ultrastructural alterations in endothelial mitochondria are associated with enhanced nitrotyrosine accumulation and progressive reduction of VEGF expression in sequential protocol renal allograft biopsies with calcineurin inhibitor toxicity

Transplant International

Volumn 23, Issue 4, 2010, Pages 407-416

  Sharma, Alok ^a   Jain, Sumeet ^a   Gupta, Ruchika ^a   Banerjee, Kishore Gopal ^a   Guleria, Sandeep ^a   Agarwal, Sanjay Kumar ^a   Dinda, Amit Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Endothelial; Mitochondria; Nitrotyrosine; Protocol biopsy; Ultrastructure; VEGF

Indexed keywords

3 NITROTYROSINE; CYCLOSPORIN; DACLIZUMAB; TACROLIMUS; VASCULOTROPIN; 3-NITROTYROSINE; CALCINEURIN INHIBITOR; TYROSINE; VASCULOTROPIN A;

ADULT; ARTERIOLE; ARTICLE; CAPILLARY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TUBULE CELL; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ALLOTRANSPLANTATION; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; BIOPSY; BIOSYNTHESIS; CHEMISTRY; KIDNEY TRANSPLANTATION; METABOLISM; PROCEDURES; TOXICITY; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

ADULT; BIOPSY; CALCINEURIN INHIBITORS; CYCLOSPORINE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; MALE; MITOCHONDRIA; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77649240335     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00988.x     Document Type: Article

References (36)

1. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004 4 : 1289.
2. Kaplan B, Meier-Kriesche HU. Renal transplantation: a half century of success and the long road ahead. J Am Soc Nephrol 2004 15 : 3270.
3. Sommerer C, Hergesell O, Nahm AM, et al. Cyclosporin A toxicity of the renal allograft - a late complication and potentially reversible. Nephron 2002 92 : 339.
4. Takeda A, Morozumi K, Yoshida A, et al. Studies of cyclosporine- associated arteriolopathy in renal transplantation: Does the long term outcome of renal allografts depend on chronic cyclosporine nephrotoxicity? Transplant Proc 1994 26 : 925.
5. Chapman JR, Nankivell BJ. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain. Nephrol Dial Transplant 2006 21 : 2060.
6. Josephine A, Amudha G, Kandaswamy VC, Sreenivasan PP, Varalakshmi P. Oxidative and nitrosative stress mediated renal cellular damage induced by cyclosporine a: role of sulphated polysaccharides. Biol Pharm Bull 2007 30 : 1254.
7. Navarro-Antolín J, López-Muñoz MJ, Klatt P, Soria J, Michel T, Lamas S. Formation of peroxynitrite in vascular endothelial cells exposed to cyclosporine A. FASEB J 2001 15 : 1291.
8. Lamas S. Cellular mechanisms of vascular injury mediated by calcineurin inhibitors. Kidney Int 2005 68 : 898.
9. Caramelo C, Alvarez-Arroyo MV, Yagüe Sn, et al. Cyclosporin A toxicity, and more: vascular endothelial growth factor (VEGF) steps forward. Nephrol Dial Transplant 2004 19 : 285.
10. Alvarez Arroyo MV, Suzuki Y, Yagüe S, et al. Role of endogenous vascular endothelial growth factor in tubular cell protection against acute cyclosporine toxicity. Transplantation 2002 74 : 1618.
11. Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008 358 : 1129.
12. Nacar A, Kiyici H, Ob̀üş E, et al. Ultrastructural examination of glomerular and tubular changes in renal allografts with cyclosporine toxicity. Ren Fail 2006 28 : 543.
13. Davidson SM, Duchen MR. Endothelial mitochondria: contributing to vascular function and disease. Circ Res 2007 100 : 1128.
14. Walker DM, Poirier MC, Campen MJ, et al. Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3′-azido-3′-deoxythymidine. Cardiovasc Toxicol 2004 4 : 133.
15. Yango A, Gohh R, Wang LJ, et al. The utility of 6-month protocol renal biopsy under modern immunosuppression. Clin Nephrol 2008 70 : 490.
16. Kurtkoti J, Sakhuja V, Sud K, et al. The utility of 1- and 3-month protocol biopsies on renal allograft function: a randomized controlled study. Am J Transplant 2008 8 : 317.
17. Kambham N, Nagarajan S, Shah S, Li L, Salvatierra O, Sarwal MM. A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies. Clin J Am Soc Nephrol 2007 2 : 135.
18. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003 349 : 2326.
19. Kim JY, Suh KS. Light microscopic and electron microscopic features of cyclosporine nephrotoxicity in rats. J Korean Med Sci 1995 10 : 352.
20. Sacchi G, Benetti A, Falchetti M, et al. Ultrastructural renal findings in allografted kidneys of patients treated with cyclosporin A. Appl Pathol 1987 5 : 101.
21. Servais H, Ortiz A, Devuyst O, Denamur S, Tulkens PM, Mingeot-Leclercq MP. Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation. Apoptosis 2008 13 : 11.
22. Quintero M, Colombo SL, Godfrey A, Moncada S. Mitochondria as signaling organelles in the vascular endothelium. Proc Natl Acad Sci U S A 2006 103 : 5379.
23. Culic O, Gruwel ML, Schrader J. Energy turnover of vascular endothelial cells. Am J Physiol 1997 273 : C205.
24. Spahr R, Krutzfeldt A, Mertens S, Siegmund B, Piper HM. Fatty acids are not an important fuel for coronary microvascular endothelial cells. Mol Cell Biochem 1989 88 : 59.
25. Lopez-Ongil S, Saura M, Rodriguez-Puyol D, Rodriguez-Puyol M, Lamas S. Regulation of endothelial NO synthase expression by cyclosporin A in bovine aortic endothelial cells. Am J Physiol 1996 271 : H1072.
26. Djamali A. Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts. Am J Physiol Renal Physiol 2007 293 : F445.
27. Wolf A, Clemann N, Frieauff W, Ryffel B, Cordier A. Role of reactive oxygen formation in the cyclosporin-A mediated impairment of renal functions. Transplant Proc 1994 26 : 2902.
28. Parra Cid T, Conejo García JR, Carballo Alvarez F, de Arriba G. Antioxidant nutrients protect against cyclosporine A nephrotoxicity. Toxicology 2003 189 : 99.
29. Padi SS, Chopra K. Salvage of cyclosporine A-induced oxidative stress and renal dysfunction by carvedilol. Nephron 2002 92 : 685.
30. Padi SS, Chopra K. Selective angiotensin II type 1 receptor blockade ameliorates cyclosporine nephrotoxicity. Pharmacol Res 2002 45 : 413.
31. Nielsen FT, Jensen BL, Marcussen N, Skøtt O, Bie P. Inhibition of mineralocorticoid receptors with eplerenone alleviates short-term cyclosporin A nephrotoxicity in conscious rats. Nephrol Dial Transplant 2008 23 : 2777.
32. Tarpey MM, Fridovich I. Methods of detection of vascular reactive species; nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res 2001 89 : 224.
33. Castilla MA, Arroyo MV, Aceituno E, et al. Role of vascular endothelial growth factor (VEGF) in endothelial cell protection against cytotoxic agents. Life Sci 2000 67 : 1003.
34. Villegas G, Lange-Sperandio B, Tufro A. Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int 2005 67 : 449.
35. Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation 1998 66 : 1736.
36. Junichi Y, Shinji T, Rie MN, et al. Tacrolimus but not cyclosporine A enhances FGF-2-induced VEGF release in osteoblasts. Int J Mol Med 2009 23 : 267.